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Abstract
Background: Little is known about the general medicines management issues for people with dementia living in
the community. This review has three aims: firstly to explore and evaluate the international literature on how
people with dementia manage medication; assess understanding of medicines management from an informal
carers perspective; and lastly to understand the role that healthcare professionals play in assisting this population
with medicines management.
Methods: A mixed studies review was conducted. Web of Knowledge, PubMed and Cochrane Library were
searched post-1999 for studies that explored medicines management in people with dementia dwelling in the
community, and the role healthcare professionals play in supporting medicines management in people with
dementia. Following screening, nine articles were included. Data from included studies were synthesised using a
convergent synthesis approach and analysed thematically to combine findings from studies using a range of
methods (qualitative, quantitative and mixed methods).
Results: Four themes were generated from the synthesis: The nature of the disease and the effects this had on
medicines management; the additional responsibilities informal carers have; informal caregivers’ knowledge of the
importance of managing medication and healthcare professionals’ understanding of medicines management in
people with dementia. Consequently, these were found to affect management of medication, in particular
adherence to medication.
Conclusions: This review has identified that managing medication for people with dementia dwelling in the
community is a complex task with a frequently associated burden on their informal caregivers. Healthcare
professionals can be unaware of this burden. The findings warrant the need for healthcare professionals to undergo
further training in supporting medicines management for people with dementia in their own homes.
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Background
Dementia has an estimated global prevalence of over 35
million people and affects over 0.5% of the global popula-
tion with annual societal costs of $604 billion [1]. As the
disease progresses, people with dementia are at risk of de-
veloping medication related problems and becoming non-
adherent to prescribed regimens [2–4]. This can be caused
by a number of factors, such as inadequate knowledge re-
garding medication, which may result in incorrect doses or
administering the treatment at an inappropriate time of the
day [5]. Additionally, issues with medication can occur if an
individual exceeds the required amount or if mistakes are
made in the prescribing, dispensing or administration
process [5, 6]. The risks associated with medication can pro-
liferate if the person with dementia is on a complex medica-
tion regimen due to co-morbid conditions [5, 7]. Medicines
management and issues with medication is an international
problem that is not just restricted to the UK [7–9].
The two most commonly used terms to describe the
process of safe and effective medicines use are ‘medi-
cines management’ and ‘medicines optimisation’. Medi-
cines management is defined as: “the entire way that
medicines are selected, procured, delivered, prescribed,
administered and reviewed to optimise the contribution
that medicines make to producing informed and desired
outcomes of patient care” [10]. The relative new term of
medicine optimisation is defined as “a person-centred
approach for the most safe and effective use of medica-
tion to ensure the best possible outcome for the patient”
[11]. The term medicines management has been in use
longer and is used throughout this article to capture a
broader chronological range of articles.
Effective medicines management requires the involve-
ment the person with dementia, the informal carer and
multiple healthcare professionals [12]. In order to gain a
full and meaningful appreciation of medicines manage-
ment, it is arguably important to address all three points
of view. To date, much research has focused on the stress
and coping techniques found in caring for someone with
dementia without reference to the particular impact of
medication and its management [13]. Other research has
presented a significant but partial view: either focusing on
the perspective of the person with dementia and their
carer as part of a more general review [8] or focused on
the challenges of medicines management across both the
community and care home settings without the perspec-
tive of healthcare professionals as part of this [14].
It is important to understand medicines management in
the community as a setting reliant on the interdependent
relationships between all three strands of the equation, as
the person with dementia, informal carers (family or friends
with an unpaid caring role), and healthcare professionals at-
tempt to engage with this issue effectively. To our know-
ledge, no studies have sought to assess and appraise
research that investigates the tripartite relationship of the
person with dementia, their informal carer and healthcare
professionals. Establishing a good understanding of this
whilst people are living in the community may help to iden-
tify methods of early detection and intervention to continue
care at home, with regards to managing medication and
may prevent or delay hospitalisation and care home
admittance.
This review aimed firstly to explore and evaluate pub-
lished international literature on understanding how
people with dementia manage medication whilst living in
the community. Secondly, it sought to gain understanding
of what is known about the effect of managing care-
recipients’ medication on informal carers. Thirdly, the way
in which healthcare professionals support people with de-
mentia and their informal caregivers with medicines man-
agement was assessed.
Methods
A mixed studies review methodology was adopted, which
enabled the consideration of contextual factors in the
investigation of medicines management in people with
dementia [15].
Data sources
PubMed, Web of Science and Cochrane Library were
initially searched in November 2014 with restrictions to
English and post 1999. Searches were updated several
times and a final search was completed in January 2017
(with two further papers being included).
Search strategy
Consultations with an information specialist and IM and
AH were used to generate preliminary search terms to
see if this resulted in relevant articles being found. This
iterative approach developed and refined the search
terms. The search strategy is included in Table 1. LA
conducted the search and evaluated potentially relevant
articles to include in this review. The list of identified
studies was independently assessed by IM. Any disagree-
ments about inclusion were discussed and resolved by
consensus by LA and IM.
Inclusion criteria
Studies included:
 Were set in the community, in the homes of people
with a diagnosis of dementia.
Table 1 Search strategy
Topic Search terms
Medication “dementia” OR “alzheimers disease”
AND
“caregiver” OR “carer” OR “family carer” OR “informal carer”
Aston et al. BMC Geriatrics  (2017) 17:242 Page 2 of 11
 Primary research only - using any design method
including randomised controlled trials, intervention
studies and studies using quantitative, qualitative
and mixed methods data.
 Full text papers.
 Covered the perspective of either the person with
dementia, informal caregiver to someone with
dementia and/or healthcare professionals regarding
medicines management in people with dementia in
the community.
Exclusion criteria
 Focussed on elderly people or other conditions as
well as dementia i.e. schizophrenia/Parkinson’s
Disease (PD), thereby lacking specificity.
 Care home settings.
 Involved end-of-life care.
 Focussed on the treatment of Behavioural and
Psychological Symptoms of Dementia (BPSD),
complimentary medicine or pharmacology of
specific drugs rather than general medicine
management.
 Involved specific medications without a focus on
medicine management.
 Non-English language studies (translation facilities
were not available).
 Pilot studies and secondary analysis papers such as
literature reviews were excluded.
Critical appraisal
LA, AH and TM independently assessed the study quality
of the included papers using the Mixed Methods Ap-
praisal Tool (MMAT) [15]. This tool is purposely designed
to appraise the methodological quality of studies that use
a range of methods [15]. The MMAT is a validated check-
list, providing a set of criteria for screening questions,
which are applied across the included studies, providing a
score for each study. Adopting the MMAT meant that it
was possible to appraise studies with different methodo-
logical designs using the same tool [16]. LA, AH and TM
discussed the quality ratings of the included studies based
on the MMATand agreed, by iteration, on the final quality
score for each.
Data extraction and synthesis
A convergent synthesis approach was adopted using the-
matic analysis [16]. All data were extracted into the
same file: qualitative data were copied verbatim; quanti-
tative data presented numerically in tables or figures
were summarised in words sometimes using interpreta-
tions from the discussion sections of papers. Extracted
qualitative and quantitative data comprise both verbatim
extracts from participant accounts (in the case of
qualitative work) and verbatim extracts from authors’ in-
terpretations (in the case of qualitative research from
the results section and in quantitative papers from the
discussion section). It is commonplace for syntheses of
this nature to include as data, therefore, extracts from
authors’ interpretative analyses because this is a second-
ary analysis of included studies [17].
The file containing the extracted data was presented
as a matrix organised by studies and themes identified in
the results of included studies. This matrix was then
searched to identify commonalities across papers. This
process was similar to the constant comparison tech-
nique often used in grounded theory and involved
highlighting data that were comparable across studies
and coding them into categories which represent those
common themes [18–20].
Following that, an interpretative thematic analysis took
place, informed by the thematic analysis of primary data
[21]. This meant looking at the common themes identi-
fied and exploring their meaning in relation to the re-
view question: we asked what each category told us
about the phenomenon of medicines management in the
community among people with dementia. This process
is referred to as a convergent synthesis, which means
that all data are taken together, interpreted, and repre-
sented as a set of themes developed through an inter-
pretative secondary analysis [16]. LA led the convergent
synthesis and discussed the emerging themes with IM.
LA and IM discussed and further developed the themes
and agreed the final set.
Results
Study selection
The search yielded 567 references, which were screened
in accordance to the inclusion criteria (see Fig. 1). This
was followed by “reference chaining” of those studies in-
cluded. Referencing chaining in this context involved
looking at the references that papers included in the
study had used. These were then screened by title to de-
termine if there were any further papers deemed suitable
for further reading. Papers were screened by title and ab-
stract; any potential papers for inclusion were read fully
before including or excluding. Searches were re-run sev-
eral times throughout the research period to ensure no
new literature was published, the final search was Janu-
ary 2017. Three papers focused on medicines manage-
ment in people with dementia and informal carers [12,
22, 23], two papers focused purely on informal carers
[24, 25], one solely on people with dementia [26], two
combining people with dementia, informal carers and
healthcare professionals [27, 28] and one paper explored
attitudes of community pharmacists towards people with
dementia [29]. Nine studies were included in the review
(see Table 2).
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Potentially relevant published papers 
identified by searching databases
n=567
Potentially relevant published papers 
retained for scrutiny of abstracts
n=94
Papers excluded after screening titles
n=473
Removal of duplicates 
n=5
Abstracts retrieved for scrutiny 
n=103
Full published papers retrieved for detailed 
evaluation
n=23
Papers excluded after scrutiny of abstracts 
on basis of inclusion criteria
n=80
Papers added from reference chaining 
n=14
Published papers included in the review 
n=9
Papers excluded after detailed evaluation 
based on inclusion criteria (reasons for 
exclusion: not in English; pre -1999;
focused on elderly people or other 
conditions Parkinson’s 
disease/schizophrenia; care home 
settings; involved end-of-life care;
involved specific medication without a 
focus on medication management
n = 16
Papers added from re-run of searches 
n= 2
Fig. 1 PRISMA flowchart
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Table 2 Characteristics of included studies
First author
& date
Journal Aim Sampling
Method
n = Location Data collection Analysis Quality
rating
Barry (2013) International
Journal of
Geriatric
Psychiatry, 28,
1077-1085.
To explore community
pharmacists’ experiences with
and attitudes towards people
with dementia (focussed on
pain).
Purposive Community
pharmacists:
182
Northern
Ireland
Questionnaire Descriptive
analyses and
Chi-square
and Fisher’s
exact test
50%
Fiss (2013) International
Journal of
Geriatric
Psychiatry, 28,
173-181.
To analyse the occurrence of
Potentially Inappropriate
Medication (PIM) taken by elderly
individuals in the AGnES studies
in primary care.
Convenience Patients: 342 Germany German
PRISCUS list
Phi
coefficient
and multiple
binary
logistic
regression
analysis
75%
Gillespie
(2015)
Dementia, 14,
47-62.
The study aimed to explore the
views of ethnic minority informal
caregivers of people living with
dementia and their medicines
management experience including
the adequacy of their access to
medication management
information and support.
Purposive Caregivers: 29 Australia Focus groups
and individual
interviews
Thematic
analysis
50%
Kaasalainen
(2011)
Journal of
Nursing and
Healthcare of
Chronic Illness,
3, 407-418.
The purpose of this grounded
theory study was to explore the
personal experiences related to
medicines management of
community-dwelling older adults
diagnosed with dementia, their in-
formal caregivers and healthcare
professionals who assist them.
Theoretical
sampling
Community
health nurses:
10
Pharmacists:
10
Family
Physicians: 6
Informal
caregivers: 20
People with
dementia: 11
Canada Interviews Grounded
theory
50%
Maidment
(2017)
Health
Expectations,
20, 929-942.
To describe and understand the
key challenges, in relation to
medication issues, experienced
by people with dementia and
their informal carers dwelling in
the community and the
potential role of community
pharmacists
Purposive
and
snowball
effect
Informal
carers: 11
GPs: 4
Nurses: 5
Social care
professionals:
3
Community
pharmacists:
4 People with
dementia: 4
UK Interviews Framework
analysis
75%
McKenzie
(2013)
American
Journal of
Alzheimer’s
Disease & other
Dementias, 28,
348-354.
The primary aim of this article is
to report the implementation
and adoption of the Safe Home
Program and the caregiver
assessments of these
technologies and devices to
determine which one may be
used to support caregivers.
Purposive People with
dementia: 60
USA Questionnaires
and interviews
Not specified 75%
Poland
(2014)
BMC Research
Notes, 7, 463.
The paper aims primarily to
describe the Public Patient
Involvement process which was
intended to inform the
development of a future
research proposal
Purposive Carers: 9 UK Focus group Thematic
analysis
100%
Smith
(2014)
International
Journal of
Pharmacy
Practice, 23, 44-
51.
The aims of this study were to
examine the scope and range of
medicines related assistance
provided by informal carers of
people with dementia, the
problems that arise and to
Convenience Carers: 14
Care-
recipients: 5
UK Interviews A framework
analysis
75%
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Study quality
The critical appraisal (MMAT) of the included studies
showed a variation in their quality (see Table 2). Consider-
ation for contextual influences and researchers’ influence
on the research conduct was lacking [12, 23, 24, 27].
Transparency of recruitment procedures was lacking in
one paper [26]. The quality of included studies varied (a
summary quality is in Table 2). Papers judged to be poorer
quality were not excluded as it was still important to in-
clude their findings. However, studies rated to be higher in
quality were given greater ‘weight’, in that these papers
were discussed more in the synthesis [17].
Study characteristics
Six studies used qualitative methods [12, 23–25, 27, 28],
two used quantitative methods [26, 29], and one used a
mixed methods design [22]. Four studies were con-
ducted in the UK and Northern Ireland [23, 25, 28, 29],
two in Australia [12, 24], one in the USA [22], one in
Canada [27] and one in Germany [26] (see Table 2).
Synthesis
The results of included studies generated four themes:
1) Effects of dementia on medicines management and
the use of adherence aids
2) Impact on informal carers
3) Knowledge of medication as an aid to adherence
4) Healthcare professionals’ understanding of medicines
management in people with dementia
Effects of dementia on medicines management and the use
of adherence aids
With any increasing severity of dementia adherence be-
came more challenging [12, 24, 29]. Informal carers
commented that as their care-recipients no longer
understood the importance of taking medication this
could result in non-adherence. “My husband he remem-
bers, he takes his own medication what [sic] he like but
he only takes the blood pressure tablets because the other
tablets he thinks do not do anything to him so it’s no
worth to take it” [24]. This calculation of whether medi-
cation makes a difference to the person with dementia is
portrayed here, which affected adhering to prescribed
medication. This increased risk in non-adherence to
medication occurred even when people with dementia
have informal carers present [29]. One study found
people with dementia received more support with drug
administration compared to those without dementia “de-
mentia: 72.0%; no dementia: 36.8%” [26].
The determination of people with dementia to con-
tinue to manage their own medication was found in five
studies [12, 23, 24, 27, 28]. People with dementia wanted
to “develop and maintain an ability to remember their
regime” [23] and some informal carers appeared to sup-
port their autonomy [24]. Nevertheless, due to the pro-
gressive nature of dementia, the person’s ability to
remember to take and manage their medication was an
issue that was commented upon in over half of the in-
cluded studies [12, 23, 26–28]. “At first she was taking
them every time and then it sort of degraded… She was
getting worse as time was going on” [12].
Some people with dementia recognised a change in
their own cognitive ability to manage their medication
which seemed to cause them distress: “He was very defi-
ant about the fact that he had taken his medication and
then he was very embarrassed when he found he hadn’t”
[12]. However, others seemed more accepting of their in-
formal carers being involved: “Well my family need to
know all about it… Because there is no point telling me,
so they have to know everything” [23] thus presenting a
difference in coping strategies of living with dementia.
Adherence packs were commented upon by informal
carers. Some informal carers organised for the adherence
packs to be made up by their pharmacist and these ap-
peared to initially help in the early stages of dementia or
had worked for a time but as the disease progressed and
further cognitive decline occurred, these aids became less
helpful [24]. In order to help reduce non-adherence, one
study implemented a ‘safe home programme’ where
Table 2 Characteristics of included studies (Continued)
First author
& date
Journal Aim Sampling
Method
n = Location Data collection Analysis Quality
rating
identify how service provision
could become more responsive
to these needs.
While
(2012)
Dementia,
12, 734-750.
This paper examines the
perspectives of the person with
dementia and their carers to
explore if there are any
significant differences in their
medicines management
experiences when compared to
older adults without dementia
and their carers.
Purposive
and
snowballing
approach
People with
dementia: 8
Informal
carers: 9
Australia Interviews Thematic
data analysis
and critical
analysis
75%
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informal carers of people with dementia were provided
with a medication organiser device if the care-recipients
were on a complex medication regime (>7 medications)
[22]. This device could be set to give alarms to provide an
alert to the informal carers when medication was due. In-
formal carers found this device useful as it gave them “…
the ability to set up a month’s supply of medicine” [22].
Based on the studies included in this review, this may act
as a useful tool for people with dementia in the early
stages of dementia. However, it may be too complex, for
usage, when the severity of dementia increases.
Some studies found people with dementia were resistant
to change and utilise medication aids as they did not want
to form a new routine: “My sister and I, we discussed even-
tually we will arrange blister packs for her but she really
doesn’t want to do that... she likes things the way she’s al-
ways done them” [24]. This resistance to change could re-
sult in conflict between the care recipient and carer as
discussed in theme 2. However, it might also signify that
there are other issues that need to be considered such as
stigma towards dementia, loss of sense of self and pride
when ‘failures’ of this kind are noticed. Interventions should
take into account the many transitions that people with de-
mentia and their informal carers have to go through. The
desire of people with dementia to hold on to something
that is known, although it may be more difficult, was found
to sometimes be preferable, reflecting a need for control in
organising the medication themselves [23].
Impact on Carers
As reported in one of the included articles, changes to the
prescription and the use of self-filled adherence aids in-
creased the burden and carer stress “It meant I had to
make this box every week” and “But it would be so much
easier if things would go automatically” [23]. This was
shared in another study where carers commented on the
difficulty of keeping on top of multiple medications, which
in turn meant that they would have to visit the pharmacy
“twice a week” [28]. This illustrates the critical role that in-
formal carers have in supporting medicines management.
People with dementia also reported the need to avoid
changing the regimen in order to keep things simple,
“Something new added can really throw my whole routine
off…So if things are simple … it’s easier” [27].
A study conducted in 2012 found that carers particu-
larly struggled with the role when they first took it over
“Well, this caused me a lot of burden and stress in the
beginning.” [12]. They reported that a lack of cooper-
ation from the person receiving support and any incon-
sistency in obtaining medication increased the burden
[12]. Yet another study found that carers would priori-
tise their care recipient’s health above their own “Some-
times I feel fed up but what can I do? That is my duty…I
forget my medicine but I never forget his.” [28]. Feeling
isolated without adequate support from healthcare pro-
fessionals also increased the burden [24, 25, 28]. Receiv-
ing better support from healthcare professionals may
help to alleviate a part of the burden that informal carers
feel, providing them with better provision to help their
care-recipient.
Anxiety about their competence in the role increased
the burden “I really do wish you wouldn’t ask me how I’m
coping because the word coping implies that if I’m not, it’s
my fault” [25]. This may be related to issues such as the
stigma of living with and caring for someone with demen-
tia, due to the lack of public awareness and understanding
of the disease. It is also wrapped up within a deep sense of
responsibility that the carer feels in having to care for
someone with dementia in the ‘accepted’ way. Carers
found complex regimens confusing “And he was put on
further more tablets. I don’t know what they are for or
what they are” [24]. The transition between the person
with dementia self-medicating and medication being man-
aged by the informal carer could be particularly stressful.
The informal carer needs to make a judgement that the
person with dementia can no longer safely manage their
medication, inform the person and take control. This need
to balance safety with a person-centred approach can re-
sult in conflict. “He said ‘what do you think!? Do you think
I can’t manage medications!?’” [24].
Knowledge of medication as an aid to adherence
A number of papers found that informal carers sought
to understand the key aspects of their care-recipient’s
medication [23–25]. This again is connected to the in-
creased dependence on informal carers. Many informal
carers across the studies discussed how they actively
sought information about medicines and their side ef-
fects: [23–25] “They (informal carers) described reading
package information, researching on the internet, maga-
zines, telephone calls to a doctor and two carers had ac-
cess to a British National Formulary (BNF)” [23].
Another study found that some informal caregivers were
concerned about the effects that the medication was hav-
ing on their loved ones, and questioned the benefits of
taking it [28]. Informal carers were shown to question the
decision of the healthcare professionals in the medication
that they had prescribed for their care-recipient; this was
linked to an increased risk of non-adherence. One reason
for this may have been due to the lack of difference they
saw in their care-recipients, which initiated questions as
to the usefulness of the medication prescribed: “I need to
see Dr X, I really do…the tablets that she's on, they are not
doing anything. I often wonder…to experiment and not give
her any tablets at all for a week and see what the outcome
would be” [28]. This assumed responsibility for determin-
ing whether the medication was working and the amount
that should be given was found in the next quote: “[Doctor
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said] Every three days, but I don’t give it to her every three
days because it’s a morphine patch, it’s for pain. She isn’t
saying that she’s...any pain. Following the prescription she’d
be taking 8 paracetamol a day which I think is far too
much to be honest with you” [28]. This self-appointed un-
derstanding of what was best for the person with de-
mentia was acknowledged and may demonstrate the
lack of opportunity informal carers felt they had in com-
municating problems with healthcare professionals,
thus presenting a barrier to effective medicines manage-
ment (see theme 4).
One study deemed to be of high quality based on the
MMAT, found that informal carers wanted healthcare
professionals to provide them with a “checklist” that pre-
sented basic information in plain language regarding the
medication that their care-recipients were taking; this
should include “…their (medication) effects, side effects
and usage instructions” [25]. This suggests that greater
understanding and knowledge about medication is valu-
able to informal carers and in turn may help to encour-
age optimal medicines management.
Healthcare professionals’ understanding of medicines
management in people with dementia
Carers reported that Health or Social Care Professionals
may be unaware of this burden and the challenge associ-
ated with medicines management [12, 28], including prac-
tical daily issues “Don’t forget that the clinician and
pharmacist can have little or no understanding of the
practicalities” [25] yet a key part of the healthcare profes-
sional’s role is dementia care. One study sent question-
naires to pharmacists about their involvement with people
with dementia, specifically regarding their knowledge
about the management of pain in this population; they
found that: “…nearly all respondents (91.2%) had provided
pharmaceutical care to people with dementia living in
their own homes” [29] and most would often support the
person with dementia’s informal carers. However, findings
suggest that pharmacists showed uncertainty in treating
people with dementia, in regards to assessing and treating
pain. This was highlighted in the: “large proportion of re-
spondents who chose to ‘neither agree nor disagree’ with
certain statements” [29]. The majority of pharmacists had
not received any recent training in dementia (95.6%), sug-
gesting a potential lack of awareness in how to best help
people with dementia. Respondents also showed a lack of
knowledge surrounding the struggles that people with de-
mentia may have with their medication, for example swal-
lowing oral dosage forms [29].
One study found that one healthcare professional felt it
was important to support the informal carer directly, “So
that's where the help needs to be improved, empowering
carers…You can't empower the patients because they're
already losing them (to the symptoms of dementia)” [28].
Additionally, one healthcare professional commented on
the importance of clarity, stating that “Written instructions,
pictures and making sure that their…family understand
what to do” [28]. Further to this, one healthcare profes-
sional listed the support required for a person with demen-
tia and their informal caregiver: “Well, if they’re having
problems taking it at the right time then I would say social
services because they’d need prompting to take it. If it was
because they couldn’t open bottles or they were getting pills
mixed up, because you, like, you might get several tablets
that look the same. You know, so that would be the pharma-
cist because you need identification. If it was because, like
with PRN medication, you would maybe need a nurse to
help them identify when they needed certain drugs.” [28].
Similarly to this, one healthcare professional commented
that care should be taken in the development of a medica-
tion regimen for people with dementia and their informal
caregivers: “If you’ve got a choice of inhaler but have these
twice a day...or there’s one that’s once a day you’d, hopefully,
go for the one that’s once a day one if it carries the appropri-
ate medication. So, it’s just simplifying everything…get them
the best medication possible, make it simple and then they
are going to use it” [28], thus demonstrating an application
in practice to understanding and optimising medication in
people with dementia.
Informal carers valued the partnership of healthcare
professionals and themselves: “If I didn’t have the relation-
ship with the GP that I do, mum wouldn’t be at home;
she’d be in a nursing home because I wouldn’t cope” [12].
As well as this, values were placed on the collaborative
partnership between healthcare professionals working to-
gether: “The ideal was when the GP and pharmacist
would work collaboratively” [12]. However, there may be
structural barriers to such collaborative working: “I have
no good contact with my mother’s GP. I cannot reach her
normally, only by receptionist or by post” [23].
Discussion
As far as we are aware, this is the first literature review
that has focussed on medicines management in people
living in the community with dementia. Other reviews
have included people living in care homes [14] and cov-
ered older people in general [8, 14]. Furthermore neither
of these studies included the views of healthcare profes-
sionals or used an appraisal tool to assess the quality of
the papers [8, 14]. Compared with these earlier reviews,
there is limited data specifically focussed on medicines
management in people living in the community with de-
mentia. This current review also included the experi-
ences of this population with healthcare professionals.
People with dementia may lack the ability to understand
and manage their medication. This increases the risk of
non-adherence and results in informal carers taking on
responsibility for medicines management as dementia
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progresses. This change in responsibility may affect the
quality of life of the informal carer.
This review has identified the impact that medicines
management responsibilities have on informal carers of
people with dementia. The burden grew with increased
complexity of the treatment regimen. This is reflected in
other research that focused on general caregiving, not spe-
cifically for people with dementia [30] and not within the
context of medicines management [31] and found infor-
mal carers often work out how to carry out their responsi-
bilities through “trial and error”, due to the lack of prior
knowledge or experience in the role [30, 31]. Similar to
theme 2 looking at carer burden, research conducted on
older adults has suggested carer burden may increase if in-
formal caregivers have to balance administration of
medication with other responsibilities [32]. Maintaining
continuous supplies of medication, especially when infor-
mal carers have work commitments, and deciding if the
care recipient was showing side effects from the medica-
tion have also been expressed as challenges [33]. This
challenge was linked to informal carers struggling with
interpreting information about the medication on the
package inserts [33], which in the above review was shown
to affect medication adherence (theme 2).
Overall medication adherence appears to be a chal-
lenge in people with dementia and so this group war-
rants further attention to develop ways of helping them
continue to take their medication in a shared decision
making model. Although the progressive nature of the
disease creates difficulty for people with dementia to ad-
here correctly to their medication, it is still important to
find ways for them to feel a part of the decision making
process. This may involve adopting or adapting a shared
decision making approach in the context of the cognitive
abilities of the person with dementia.
Supporting medication adherence, especially with the use
of adherence aids was an important concern found in this
synthesis, especially in Themes 1 and 3. Adherence aids
were one strategy used with varying degrees of effective-
ness; these tended to only work in the early stages of the
disease. Interventions targeted at providing education to
caregivers on medicines management appear to be a sound
basis for increased adherence. Teaching the care-recipient
about medication could help with adherence [34]. However,
educational interventions should consider the practical is-
sues associated with administration faced by informal carers
and support medicines management rather than solely fo-
cusing on adherence [35]. The training required for any
educational intervention must be widely accessible for in-
formal carers. Workshops where informal carers could
meet and learn from each other may be helpful; however,
some informal carers may not be able to leave their care-
recipient unattended [30]. Not all informal carers may have
the technological skills to use the internet [32].
Additionally, informal carers valued the chance to ask ques-
tions, which may be easier face-to-face.
This synthesis found that collaborative partnerships be-
tween informal carers and healthcare professionals were
valued by informal caregivers and that healthcare profes-
sionals need to understand the varied role of informal
carers (theme 4). Theme 4 also found that interventions
to support medicines management for people with de-
mentia should increase healthcare professionals’ aware-
ness of the difficulties that informal carers face and the
support that is available for them. Appropriately trained
healthcare professionals should conduct regular medica-
tion reviews and ensure that their patients who have de-
mentia are on the most straightforward routine available
for them [36, 37]. A dementia training intervention, which
included a physician-training program and support from
local dementia service providers, assisted in improving de-
mentia care in the primary care environment [38].
Implications for healthcare professionals and
policymakers
Healthcare professionals should be aware of the chal-
lenges faced by people with dementia and their informal
carers and recognise the need for regular, on-going sup-
port [36]. However, as we found in theme 4, healthcare
professionals may need specialist training in dementia
care, especially in the responsibilities that informal
carers face in looking after someone with dementia [13,
31, 39]. The role played by informal carers in the care of
older adults has been formally recognised with the publi-
cation of new guidance for patient- and family-centred
care [40]. Policy in this area should apply the principles
of a patient-centred approach [40, 41]. Individualised
care should be extended to support informal carers of
people with dementia to enable sound medicines man-
agement without creating an excessive burden [41] a
concern, which was highlighted in Theme 2.
Limitations of the study
This review identified a relatively small number of stud-
ies, which demonstrates a lack of research conducted in
the field both nationally and internationally. The results
of this mixed studies review should be interpreted with
caution due to the limitations of the included studies.
Transparency of reporting is key to establishing the
trustworthiness of findings and in turn improve the
quality of the evidence base for future research and
healthcare interventions [42]. Some studies in this re-
view were appraised as poorer quality due to a lack of
transparency in methods used [24, 27, 29]. Some of the
included studies that adopted a qualitative methodology
failed to adequately recognise and prevent researcher
bias [12, 23, 24, 27]. The desire of carers to give the
“correct response” to the interviewer may have affected
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the results [24]. There is also the potential of recall bias
from the interviews conducted [26]. Some studies failed
to adequately consider the impact of the context in
which the data were collected on the findings [22], or
had a low response rate affecting the generalisability of
the results [29]. Triangulation with an independent data
collection method, such as a daily diary entry of informal
carers’ experiences of medicines management, may be a
more appropriate way of understanding the challenges
and may in turn help to reduce any researcher influ-
ences. In spite of these limitations, it should be noted
that this review has brought together the current evi-
dence and highlighted the areas that require additional
focus through higher quality research.
Future research
Further qualitative work should aim to understand more
about how different groups of people with dementia and
their carers manage their medication and the level of
support they require. It would be beneficial to hear from
a wide range of health and social care professionals, and
understand their role in helping people with dementia
manage their medication and the role of shared decision
making in medication optimisation. Informed by the
current evidence base and the future qualitative work an
intervention to aid medicines management should be
developed in line with the Medical Research Council
framework for developing complex interventions [43].
Conclusion
This mixed studies review identified that managing
medication for people with dementia dwelling in the
community is a complex task with a frequently associ-
ated burden on their informal caregivers. The risk of
non-adherence exists even when the person with de-
mentia is supported by an informal carer and even when
adherence aids are used. Healthcare professionals may
be unaware of this burden.
The need for informal carers to understand the pre-
scribed medication and the benefits of taking it, as well as
the need for support from healthcare professionals, was
shown to be important to both the person with dementia
and their informal carers. Healthcare professionals may
need to undergo further training in supporting medicines
management for people with dementia in their own
homes. Overall, informal carers have a critical role in sup-
porting medicines management in people with dementia
and a patient-centred approach, to individual care, should
be fully extended to enable informal carers to support
people with dementia with their medication.
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